Join to view full profile
1203 S Tyler StSte 100Covington, LA 70433
Phone+1 985-892-9090
Fax+1 985-892-9957
Dr. Carinder is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Board certified in both Medical Oncology and Hematology with a special interest in Hematologic malignancies, hemostasis and thrombosis and neoplastic diseases of the breast.
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1997 - 2000
Cleveland Clinic FoundationResidency, Internal Medicine, 1994 - 1997
Oklahoma State University Center for Health SciencesClass of 1994
Certifications & Licensure
LA State License 2004 - 2026
AL State License 2000 - 2018
OH State License 1995 - 2001
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2012, 2014, 2017
- CMS Meaningful Use Stage 2 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2012, 2014, 2017
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
Publications & Presentations
PubMed
- 9 citationsRahnella aquatilis bacteremia in a patient with relapsed acute lymphoblastic leukemia.James E. Carinder, Jimmy Chua, Roberto B. Corales, Alan J. Taege, Gary W. Procop
Scandinavian Journal of Infectious Diseases. 2001-01-01
Press Mentions
Reputable Hematologist and Oncologist, James Everett Carinder, DO, FACP, Will Be Noted in the Leading Physicians of the WorldMay 22nd, 2018
Proficient Hematologist and Oncologist, James Everett Carinder, DO, FACP, Will Be Displayed in the Leading Physicians of the WorldApril 17th, 2017
Mary Bird Perkins Cancer Center Expands Partnership with NOAJuly 27th, 2021
Grant Support
- Repurposing Pyrvinium as an Inhalation Therapy for Idiopathic Pulmonary FibrosisOLEOLIVE, INC.2025–2027
- Evaluation of a dual PPAR agonist for treatment of Alzheimer's diseaseOLEOLIVE, INC.2019–2025
- Evaluation of a dual PPAR agonist for treatment of Alzheimer's diseaseOLEOLIVE, INC.2019–2025
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










